Identification of Cell Surface Targets Based on Gene Amplification/Overexpression
基于基因扩增/过表达的细胞表面靶点鉴定
基本信息
- 批准号:8555330
- 负责人:
- 金额:$ 41.79万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-21 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAreaBindingBiopsy SpecimenCandidate Disease GeneCarcinoma in SituCell LineCell Surface ProteinsCell surfaceCellsClinicalColorectal CancerDatabasesDetectionDevelopmentDysplasiaERBB2 geneEndoscopesEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEsophagealEsophageal AdenocarcinomaEsophageal TissueEsophageal mucous membraneExcisionFrequenciesGene AmplificationGene ExpressionGenesGoalsImageImmunohistochemistryIn VitroIncidenceInterventionLabelMMP11 geneMMP3 geneMalignant NeoplasmsMembrane ProteinsMessenger RNAMetaplasiaMethodsMichiganMolecular BiologyNeoplasmsOperative Surgical ProceduresPatientsPeptidesPremalignantPrincipal InvestigatorProteinsResearchReverse Transcriptase Polymerase Chain ReactionRoche brand of trastuzumabSamplingScanningScreening for cancerSequence AnalysisSpecimenSurfaceSurveillance MethodsTelomeraseTherapeuticTissuesUniversitiesValidationWestern Blottingbaseexpression vectorimaging modalityimmunocytochemistryimprovedinnovationmeetingsmolecular imagingneoplasticnoveloptical imagingoverexpression
项目摘要
A panel of 15 candidate targets will be identifed based on both high-frequency amplified
chromosomal regions and mRNA overexpression from a SNP array database of specimens of neoplastic
Barrett's esophageal mucosa with support from Core B. Validafion of selected gene candidates will be
performed on an independent set of 50 cases of Barrett's metaplasia, low-grade, high-grade dysplasia and
adenocarcinoma using quantitative RT-PCR and at the protein level using fissue microarrays and
immunohistochemistry with support from Core C. This panel will be reduced to the 5 best candidate amplified
and/or overexpressed cell surface genes will be transfected into immortalized Barrett's metaplasia cells for in
vitro selection of imaging peptides in Project 2 for imaging with a mulfi-spectral scanning flber endoscope
developed in Project 3.
一组15个候选目标将根据两个高频放大
来自肿瘤样本SNP阵列数据库的染色体区域和mRNA过表达
Barrett食管粘膜,支持核心B。将对选定的候选基因进行验证
对50例Barrett化生、低度、高度异型增生和
使用定量RT-PCR和使用裂隙微阵列在蛋白质水平检测腺癌,
免疫组化支持核心C。这个小组将减少到5个最好的候选人放大
和/或过表达的细胞表面基因将被转染到永生化的巴雷特化生细胞中,
多光谱扫描纤维内窥镜成像的项目2中成像肽的体外选择
在项目3中开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID George BEER其他文献
DAVID George BEER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID George BEER', 18)}}的其他基金
RNF128 Regulation of TP53 in Barrett's Progression
RNF128 对 Barrett 进展中 TP53 的调节
- 批准号:
10219176 - 财政年份:2017
- 资助金额:
$ 41.79万 - 项目类别:
Biomedical Computing and Informatics Strategies for Precision Medicine
精准医学的生物医学计算和信息学策略
- 批准号:
9366045 - 财政年份:2017
- 资助金额:
$ 41.79万 - 项目类别:
RNF128 Regulation of TP53 in Barrett's Progression
RNF128 对 Barrett 进展中 TP53 的调节
- 批准号:
9976469 - 财政年份:2017
- 资助金额:
$ 41.79万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8724430 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Early Targets in Progression of Barrett's Esophagus to Esophageal Adenocarcinoma
巴雷特食管进展为食管腺癌的早期目标
- 批准号:
9277831 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Identification and Characterization of Gene Fusions in Lung Adenocarcinoma
肺腺癌基因融合的鉴定和表征
- 批准号:
8018735 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Identification and Characterization of Gene Fusions in Lung Adenocarcinoma
肺腺癌基因融合的鉴定和表征
- 批准号:
8249361 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8919278 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Project 1: Identification and Validation of Panel of Early Cell Surface Gene Targets
项目 1:早期细胞表面基因靶标组的鉴定和验证
- 批准号:
10155438 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
Multi-Spectral Targeted Imaging for Early Detection of Cancer in Barrett's Esopha
多光谱靶向成像用于巴雷特食管癌症的早期检测
- 批准号:
8209767 - 财政年份:2011
- 资助金额:
$ 41.79万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 41.79万 - 项目类别: